(Q48389932)

11 February 2018

title

The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. (English)

1 reference

11 February 2018

1 reference

2

1 reference

11 February 2018

author name string

U Freo

1

1 reference

11 February 2018

M Dam

3

1 reference

11 February 2018

G Pizzolato

4

1 reference

11 February 2018

L Battistin

5

1 reference

11 February 2018

publication date

1 January 1993

1 reference

11 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

11 February 2018

volume

113

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

53-59

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02244334

exact match

0 references

cites work

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action

1 reference

https://api.crossref.org/works/10.1007%2FBF02244334

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244334

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244334

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244334

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244334

Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine

1 reference

12 December 2020

Tissue distribution of chlorimipramine and its demethylated metabolite after a single dose in the rat

1 reference

12 December 2020

The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats

1 reference

12 December 2020

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1 reference

12 December 2020

Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats

1 reference

12 December 2020

Decrease in [3H]-serotonin binding in rat brain produced by the repeated administration of either monoamine oxidase inhibitors or centrally acting serotonin agonists

1 reference

12 December 2020

Arecoline-induced elevations of regional cerebral metabolism in the conscious rat.

1 reference

12 December 2020

Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline

1 reference

12 December 2020

Serotonin release estimated by transcortical dialysis in freely-moving rats

1 reference

12 December 2020

Postmortem neurochemical studies in depression.

1 reference

12 December 2020

Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites.

1 reference

12 December 2020

Cerebral Glucose Utilization in Rats is Not Altered by Hindlimb Restraint or by Femoral Artery and Vein Cannulation

1 reference

12 December 2020

PET imaging in obsessive compulsive disorder with and without depression

1 reference

12 December 2020

Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system

1 reference

12 December 2020

Effects of antidepressant agents on the synthesis of brain monoamines

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats.

1 reference

12 December 2020

Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics.

1 reference

12 December 2020

Anatomy of the serotonergic system

1 reference

12 December 2020

Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter

1 reference

12 December 2020

Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.

1 reference

12 December 2020

5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

1 reference

12 December 2020

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin

1 reference

12 December 2020

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

1 reference

12 December 2020

Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists

1 reference

12 December 2020

The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice.

1 reference

12 December 2020

Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography

1 reference

12 December 2020

Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression

1 reference

12 December 2020

Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats

1 reference

12 December 2020

Peripheral indices of central serotonin function in humans

1 reference

12 December 2020

Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.

1 reference

12 December 2020

Serotonin and suicidal behavior

1 reference

12 December 2020

Effects of antidepressant drugs on different receptors in the brain

1 reference

12 December 2020

Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: relevance to the pathophysiology of affective dysregulation in psychiatric disorders

1 reference

12 December 2020

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

1 reference

12 December 2020

The effects of intravenous clomipramine on neurohormones in normal subjects

1 reference

12 December 2020

Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.

1 reference

12 December 2020

Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments.

1 reference

12 December 2020

Serotonergic dysfunction in depression

1 reference

12 December 2020

Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244334

1 reference

11 February 2018

1 reference

11 February 2018